New Insights into Endometrial Cancer

Area of Science:

• Gynecologic Oncology
• Cancer Immunology
• Endocrinology

Background:

• Endometrial cancer (EC) is a prevalent gynecologic malignancy in developed nations.
• Increasing incidence linked to aging and obesity highlights its public health significance.
• EC's hormone dependency is recognized, yet receptor assessment and adjuvant hormone therapy lack standardized recommendations.

Purpose of the Study:

• To review current understanding of EC management.
• To highlight the role of the tumor immune microenvironment in EC progression.
• To advocate for personalized treatment strategies in EC.

Main Methods:

• Literature review focusing on EC diagnosis, treatment, and tumor microenvironment.
• Analysis of recent evidence on immune cell interactions within the EC microenvironment.
• Synthesis of findings to propose future directions in EC management.

Main Results:

• The tumor immune microenvironment may promote immune tolerance by hindering cytotoxic immune cell infiltration and function.
• Current EC management lacks standardized protocols for hormone receptor evaluation and adjuvant hormone therapy.
• Evidence suggests a need to explore the immune landscape for therapeutic targets.

Conclusions:

• Personalized treatment approaches are crucial for advancing EC care.
• Further research into EC's immune microenvironment and hormone receptor status is warranted.
• Integrating diagnostic and therapeutic insights may improve patient outcomes.